Proliposomes for oral delivery of dehydrosilymarin: Preparation and evaluation in vitro and in vivo

Acta Pharmacologica Sinica

Volumn 32, Issue 7, 2011, Pages 973-980

  Chu, Chang ^a   Tong, Shan Shan ^a   Xu, Ying ^a   Wang, Li ^a   Fu, Min ^a   Ge, Yan Ru ^a   Yu, Jiang Nan ^a   Xu, Xi Ming ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

dehydrosilymarin; oral bioavailability; pharmacokinetics; proliposomes; silymarin

Indexed keywords

CHOLESTEROL; CHOLIC ACID; DEHYDROSILYMARIN; HERBACEOUS AGENT; LIPOSOME; MYRISTIC ACID ISOPROPYL ESTER; SILYMARIN; UNCLASSIFIED DRUG;

ARTICLE; BIOAVAILABILITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; ENCAPSULATION; FREEZE DRYING; IN VITRO STUDY; IN VIVO STUDY; MORPHOLOGICAL TRAIT; OXIDATION; PARTICLE SIZE; PH; RABBIT; SUSPENSION; TRANSMISSION ELECTRON MICROSCOPY;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; LIPOSOMES; MILK THISTLE; PROTECTIVE AGENTS; RABBITS; SILYMARIN;

EID: 79960031686     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.25     Document Type: Article

References (32)

1. Weiss R, Fintelmann V. Herbal Medicine, 2nd ed. Thieme, Stuttgart, New York, 2000. p 109-11.
2. Schuppan D, Jia JD, Brinkhaus B, Hahn EG. Herbal products for liver diseases: a therapeutic challenge for the new millennium. Hepatology 1999; 30: 99-104.
3. Wu W, Wang Y, Que L. Enhanced bioavailability of silymarin by selfmicroemulsifying drug delivery system. Eur J Pharm Biopharm 2006; 63: 288-94. (Pubitemid 43776222)
4. Xiao YY, Song YM, Chen ZP, Ping QN. Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin beagle dogs. Int J Pharm 2006; 319: 162-8.
5. Tong SS, Chu C, Wei Y, Wang L, Gao XZ, Xu XM, et al. Preparation and effects of 2,3-dehydrosilymarin, a promising and potent antioxidant and free radical scavenger. J Pharm Pharmacol 2011; 63: 238-44.
6. Chen YP, Lu Y, Chen JM, Lai J, Sun J, Hu FQ, et al. Enhanced bioavailability of the poorly water-soluble drug feno?brate by using liposomes containing a bile salt. Int J Pharm 2009; 376: 153-60.
7. Arién A, Goigoux C, Baquey C, Dupuy B. Study of in vitro and in vivo stability of liposomes loaded with calcitonin or indium in the gastrointestinal tract. Life Sci 1993; 53: 1279-90.
8. Arién A, Henry-Toulmé N, Dupuy B. Calcitonin-loaded liposomes: stability under acidic conditions and bile salts-induced disruption resulting in calcitonin-phospholipid complex formation. Biochim Biophys Acta 1994; 1193: 93-100. (Pubitemid 24234183)
9. Aungust BJ. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J Pharm Sci 1993; 82: 979-87.
10. Sivakumar PA, Panduranga Rao K. The use of cholesteryl pullulan for the preparation of stable vincristine liposomes. Carbohydr Polym 2003; 51: 327-32. (Pubitemid 35276358)
11. Lau KG, Hattori Y, Chopra S, OToole EA, Storey A, Nagai T, et al. Ultradeformable liposomes containing bleomycin: in vitro stability and toxicity on human cutaneous keratinocyte cell lines. Int J Pharm 2005; 300: 4-12. (Pubitemid 41112161)
12. Cocera M, Lopez O, Coderch L, Parra JL, de la Maza A. Permeability investigations of phospholipid liposomes by adding cholesterol. Colloids Surf A Physicochem Eng Asp 2003; 221: 9-17. (Pubitemid 36802191)
13. Dong C, Rogers JA. Polymer-coated liposomes: stability and release of ASA from carboxymethyl chitin coated liposomes. J Control Release 1991; 17: 217-24.
14. Henriksen I, Vhgen SR, Sande SA, Smistad G, Karlsen J. Interactions between liposomes and chitosan. II. Effect of selected parameters on aggregation and leakage. Int J Pharm 1997; 146: 193-204.
15. Takeuchi H, Kojima H, Yamamoto H, Kawashima Y. Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats. J Control Release 2001; 75: 83-91. (Pubitemid 32635199)
16. Guo J, Ping Q, Jiang G, Huang L, Tong Y. Chitosancoated liposomes: characterization and interaction with leuprolide. Int J Pharm 2003; 260: 167-73. (Pubitemid 36773915)
17. Winden E, Crommelin D. Short term stability of freeze-dried, lyoprotected liposomes. J Control Release 1999; 58: 69-86. (Pubitemid 29371815)
18. Glavas-Dodov M, Fredro-Kumbaradzi E, Goracinova K, Simonoska M, Calis S, Trajkovic-Jolevska S, et al. The effects of lyophilization on the stability of liposomes containing 5-FU. Int J Pharm 2005; 291: 79-86. (Pubitemid 40221999)
19. Sweeney LG, Wang Z, Loebenberg R, Wong JP, Lange CF, Finlay WH. Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosold rug delivery. Int J Pharm 2005; 305: 180-5. (Pubitemid 41568373)
20. Hildebrand A, Beyer K, Neubert R, Garidel P, Blume A. Temperature dependence of the interaction of cholate and deoxycholate with fluid model membranes and their solubilization into mixed micelles. Colloids Surf B Biointerfaces 2003; 32: 335-51. (Pubitemid 37315913)
21. Porter CJ, Trevaskis NL, Charman WN. Lipid and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 2007; 6: 231-48. (Pubitemid 46344627)
22. Gazák R, Svobodová A, Psotová J, Sedmera P, Prikrylová V, Walterová D, et al. Oxidised derivatives of silybin and their antiradical and antioxidant activity. Bioorg Med Chem 2004; 12: 5677-87. (Pubitemid 39304066)
23. Takemoto T, Ikegawa S, Nomoto K. Studies on constituents of Silybum marianum (L) Gaertn. I. New flavonolignans named 2,3-dehydrosilymarin and 2,3-dehydrosilychristin. Yakugaku Zasshi 1975; 95: 1017-21.
24. Morazzoni P, Montalbetti A, Malandrino S, Pifferi G. Comparative pharmacokinetics of silipide and silymarin in rats. Eur J Drug Metab Pharmacokinet 1993; 18: 289-97. (Pubitemid 24009653)
25. Luper S. A review of plants used in the treatment of liver disease: part 1. Altern Med Rev 1998; 3: 410-21. (Pubitemid 128709687)
26. Křen V, Walterova D. Silybin and silymarin-new effects and applications. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005; 149: 29-41.
27. Gažák R, Walterová D, Křen V. Silybin and silymarin-new and emerging applications in medicine. Curr Med Chem 2007; 14: 315-38.
28. Xiao YY, Song YM, Chen ZP, Ping QN. The preparation of silybinphospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm 2006; 307: 77-82.
29. Yu JN, Zhu Y, Wang L, Peng M, Tong SS, Cao X, et al. Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micelles. Acta Pharmacol Sin 2010; 31: 759-64.
30. Zhu Y, Yu JN, Tong SS, Wang L, Peng M, Cao X, et al. Preparation and in vitro evaluation of povidone-sodium cholate-phospholipid mixed micelles for the solubilization of poorly soluble drugs. Arch Pharm Res 2010; 33: 911-7.
31. Cocera M, Lopez O, Coderch L. Alterations in stratum corneum lipid liposomes due to the action of Triton X-100: influence of the level of ceramides on this process. J Control Release 2000; 68: 387-96.
32. Du B, Li Y, Li XT, A YM, Chen CQ, Zhang ZZ. Preparation, characterization and in vivo evaluation of 2-methoxyestradiol-loaded liposomes. Int J Pharm 2010; 384: 140-7.